Auerbach and Kellermann 2011 — A Decade of Health Care Cost Growth Has Wiped Out Real Income Gains for an Average US Family

health-care-costshealth-insuranceemployer-sponsored-insuranceincomepremiumsout-of-pocketMedicareMedicaidfamily-budgetamenable-mortalitydescriptive

Summary

Between 1999 and 2009, a median-income US family of four with employer-sponsored health insurance saw its gross nominal income rise 30%30\% (from $76,000\$76{,}000 to $99,000\$99{,}000), but rising health care costs consumed virtually the entire real gain. After accounting for general price inflation, the family was left with only $95\$95 more per month for non-health spending — and even that modest amount was inflated by federal deficit spending that underfunded Medicare and Medicaid. The paper decomposes total family health care costs into four channels (two visible, two hidden) and shows that under inflation-rate health cost growth the family would have had $545\$545/month more.

Key Claims

Concepts Introduced or Extended

Entities Mentioned

Quotes

"Although these figures are sobering, they don't easily translate to real-world consequences for American families—because many health care costs are hidden from their view."

"As a result, we argue, the burdens imposed on all payers by steadily rising health care spending can no longer be ignored."

My Take

A descriptive accounting exercise, not a causal study. Its contribution is making hidden costs visible: employer premium pass-through (wages suppressed by \approx employer contribution) and tax-financed program spending (Medicare, Medicaid) are real costs borne by workers that standard cash-income surveys miss. The deficit complication is handled carefully with a parallel scenario. Limitations: the "typical family" is actually 70\approx 70th income percentile (employer-insured families earn 20%\approx 20\% more than median), so the headline figures likely overstate the burden for median households. The counterfactual scenarios are illustrative, not causal. The amenable mortality comparison provides suggestive evidence of poor value but does not isolate the causal return to marginal health spending. The paper predates Affordable Care Act (ACA) implementation (2010 passage, phased 2010–2014) and cannot assess whether the law bent the cost curve.